TekniPlex Healthcare has forged an exclusive, multi-year strategic agreement with David Schnur Associates (DSA) to represent its interventional devices category. DSA’s team of interventional devices technical experts spans key markets for TekniPlex Healthcare, including North and Latin America, Europe, Israel, and Turkey.  

“TekniPlex Healthcare’s Interventional Devices portfolio is a tremendous resource with strong niche technologies in complex extrusion, metal components and nitinol fabrication,” DSA CEO Barry Schnur said. “We’re excited to partner with TekniPlex Healthcare to support existing customers and to expand access to this collection of specialized interventional device solutions.”

Partnering with DSA provides TekniPlex Healthcare with a ready-made extension of its internal sales, marketing and customer management teams for selected interventional device products and services, according to the company. Working with DSA’s turnkey technical experts will afford TekniPlex Healthcare a streamlined, focused approach to expanding its evolving medical device business which, moving forward, will be subdivided into two customer service categories:

• TekniPlex Healthcare will continue to internally handle all customer engagement for its Advanced Medical Solutions portfolio, which spans various extruded tubing solutions, molded parts, and medical device compounds outside the interventional devices sphere, as well as assembly and packaging services for such products.
• DSA will support customer engagement activities for TekniPlex Healthcare’s Interventional Devices products and services, including precision polymer and metal components, complicated custom extrusions, and complex design and development projects involving implantable components (such as stents, stent grafts, and transcatheter valves), catheter constructions, delivery systems, and molding and assembly projects associated with interventional devices.

The decision to partner with DSA reflects TekniPlex Healthcare’s rapid, extensive capabilities additions in the medical device sector. With eclectic skill sets for designing and manufacturing Class III implantable components and delivery systems, TekniPlex Healthcare is among the few medical device CDMOs offering ideation-to-completion product development for endovascular stents, heart valves, and catheter delivery systems, among other categories. The company’s sweeping capabilities include high-precision, tight-tolerance development and prototyping for critical metal components necessary in interventional cardiology, radiology, neurovascular, peripheral vascular, structural heart, electrophysiology and other minimally invasive therapies.

TekniPlex Healthcare’s services supports customers from early ideation stages through product development, prototyping, clinical trials, testing, new product introduction and full production of catheter-based devices. This includes precision secondary processes and cleanroom assembly of Class II and Class III implantable components.

“Considering DSA’s exemplary reputation as true medical device specialists, partnering with their team of technical experts extends our in-house team of sales, marketing, and customer management professionals in a truly plug-and-play fashion,” TekniPlex Healthcare Sales/Marketing Vice President Bryan Wesselmann stated. “As our capabilities in the interventional devices space continue to expand and diversify to address an ever-shifting landscape, working with the DSA team makes TekniPlex Healthcare even more prepared to provide expertise-driven engineering services to our global customer base.”

TekniPlex Healthcare uses advanced materials science expertise and technologies to develop and deliver critical solutions for medical and diagnostic devices, drug delivery systems, and sterile barrier healthcare packaging applications. With a global reach, the division’s deep understanding of the greater pharmaceuticals and medical landscape helps it produce exemplary barrier properties for drugs and precision medical devices for interventional and therapeutic procedures.

In the medical device niche, TekniPlex Healthcare embodies a comprehensive CDMO partner capable of servicing every stage of the product life cycle, from design and development through component manufacturing and final assembly. Throughout its broad purview, the division’s evolving portfolio helps meet demands for high-leverage medicines and mission-critical healthcare products that benefit care providers and patients.

David Schnur Associates is a technical sales organization with more than 45 years of experience bringing material and component expertise to the medical device and life science communities. With a global network of material and service partners, DSA acts as an extension of its customers’ design, engineering and manufacturing teams.